Alexza Pharmaceuticals (ALXA)
Create an Alert
4.53
-0.06 -1.31%
NASDAQ
Jun 18, 8:00PM
BATS Real time
Currency in USD
Alexza Pharmaceuticals Revenue Quarterly:
0.729M for March 31, 2013Alexza Pharmaceuticals Historical Revenue Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 0.729M |
| Dec. 31, 2012 | 0.729M |
| Sept. 30, 2012 | 0.729M |
| June 30, 2012 | 0.728M |
| March 31, 2012 | 1.884M |
| Dec. 31, 2011 | 1.884M |
| Sept. 30, 2011 | 1.259M |
| June 30, 2011 | 1.258M |
| March 31, 2011 | 1.259M |
| Dec. 31, 2010 | 42.13M |
| Sept. 30, 2010 | 0.744M |
| June 30, 2010 | 0.00 |
| March 31, 2010 | 0.00 |
| Dec. 31, 2009 | 0.00 |
| Sept. 30, 2009 | 0.00 |
About Revenues
Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity. Increasing revenues over time are generally a good sign of company's growth.
While a bit obvious, if a lemonade company has sold 30 million in revenue and has 10 million in costs of goods sold, the company's revenue is still 30 million. (Expenses are not accounted in Revenue).
Learn More
ALXA Revenue Quarterly Benchmarks
| Companies | |
|---|---|
| Teva Pharmaceutical Industries | 4.901B |
| Forest Laboratories | 821.67M |
| POZEN | 1.415M |
ALXA Revenue Quarterly Rankings
| Overall |
55th percentile 7406 of 16773 |
| Sector |
53rd percentile 653 of 1410 in Healthcare |
| Industry |
54th percentile 69 of 152 in Drug Manufacturers - Specialty & Generic |
ALXA Revenue Quarterly Range, Past 5 Years
| Minimum | 0.000 | Jun 2008 |
| Maximum | 42.13M | Dec 2010 |
| Average | 3.167M |
